ARMATA PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Earnings Per Share, Basic and Diluted of -$0.22 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-10
- ARMATA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.22.
- ARMATA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.25.
- ARMATA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.27.
- ARMATA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.31.
- ARMATA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2016 was -$2.47.
- ARMATA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2015 was -$1.99.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | -$0.22 10-Q · filed 2021-11-10 | -$0.73 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | -$0.25 10-Q · filed 2021-08-12 | -$0.52 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | -$0.27 10-Q · filed 2021-05-13 | ||||
| 2020-09-30 | -$0.31 10-Q · filed 2021-11-10 | -$0.99 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$0.26 10-Q · filed 2021-08-12 | -$0.68 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | -$0.49 10-Q · filed 2021-05-13 | ||||
| 2019-06-30 | -$0.56 10-Q · filed 2020-08-13 | -$1.30 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | -$0.80 10-Q · filed 2020-05-14 | -$0.11 10-Q · filed 2019-05-06 | |||
| 2018-03-31 | -$0.24 10-Q · filed 2019-05-06 | ||||
| 2017-03-31 | -$1.94 10-Q · filed 2018-05-15 | ||||
| 2016-12-31 | -$2.47 10-K · filed 2017-03-27 | ||||
| 2016-03-31 | -$8.22 10-Q · filed 2017-05-15 | ||||
| 2015-12-31 | -$1.99 10-K · filed 2017-03-27 | ||||
| 2015-03-31 | -$0.07 10-Q · filed 2015-05-15 | ||||
| 2014-03-31 | -$0.06 10-Q · filed 2015-05-15 | -$0.10 10-Q · filed 2014-05-20 | |||
| 2013-12-31 | -$0.64 10-Q/A · filed 2015-04-15 | ||||
| 2013-03-31 | -$0.03 10-Q/A · filed 2015-04-15 | -$0.02 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |